Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2021-06-29 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
GLOBAL OFFERING
Capital/Financing Update Classification · 95% confidence The document is an announcement related to a Global Offering of shares by Kindstar Globalgene Technology, Inc. It includes details about the number of shares offered, pricing, application procedures, underwriting, and regulatory disclaimers. The text references the prospectus and the Hong Kong Stock Exchange listing process. It is not a financial report, earnings release, or management discussion. It is a detailed announcement about the company's capital raising activity through an initial public offering (IPO) and share allocation. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive update on financing.
2021-06-29 English
PHIP (1st submission)
Regulatory Filings Classification · 95% confidence The document is titled 'Post Hearing Information Pack' and is issued by Kindstar Globalgene Technology, Inc. It is explicitly stated to be a draft document required by the Stock Exchange of Hong Kong Limited and the Securities and Futures Commission for public information purposes. The document contains disclaimers that it is incomplete, subject to change, and not a prospectus or offering document. It includes sections such as expected timetable, summary, risk factors, corporate information, business overview, directors and senior management, substantial shareholders, share capital, and financial information. The document is related to a public offering or listing process, with references to underwriting, share subscription, and regulatory compliance. It is not a full annual or interim financial report, nor an earnings release or management discussion. It is not a proxy statement or voting results announcement. The document serves as an informational pack post hearing with regulators, providing detailed information about the company in connection with a proposed listing or offering. This type of document aligns with a Regulatory Filings (RNS) category as it is a regulatory disclosure document that does not fit into other specific report types and is not the final prospectus or report itself.
2021-06-16 English
PHIP (1st submission)
Audit Report / Information Classification · 95% confidence The document is a 'PHIP' (Post-Hearing Information Proof) for Kindstar Globalgene Technology, Inc., which is a standard regulatory filing document used in the Hong Kong Stock Exchange (HKEX) listing process. It contains a table of contents for a prospectus, including sections like 'Business', 'Financial Information', and 'Accountants' Report'. Since it is a preliminary document related to a public offering and does not fit into the other specific categories like 10-K or ER, it is classified as a Regulatory Filing (RNS). FY 2020
2021-06-16 English
Application Proof (1st submission)
Audit Report / Information Classification · 95% confidence The document is an 'Application Proof' from the Hong Kong Stock Exchange (HKEX) for Kindstar Globalgene Technology, Inc. It contains a list of links to various sections of a prospectus, including 'Industry Overview', 'Business', 'Financial Information', and 'Accountants' Report'. This structure is characteristic of an IPO prospectus filing, which falls under the 'POS' (Public Offering/Share Issue) category in many systems, but given the provided definitions, 'POS' is specifically for 'Transaction in Own Shares' (buybacks). However, since this is an application for a new listing/share issuance, and no other category fits perfectly, it is classified as a regulatory filing (RNS) or a capital-related document. Given the specific list of options, 'POS' is often used for share issuance, but 'RNS' is the safest fallback for a general regulatory filing of this nature. FY 2020
2021-02-23 English
Application Proof (1st submission)
Regulatory Filings
2021-02-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.